Partners

partners transp
WP Lead Beneficiaries
AUSTRIA TRANSP
Austria
Belgium t
Belgium
Finalnd t
Finalnd
france t
France
Greece t
Greece
Hungary t
Hungary
IRELAND TRANS
Ireland
Italy t
Italy
LATVIA TRANSP
Latvia
holland transp
Netherlands
norway trans
Norway
romania transp
Romania
Slovenia t
Slovenia
Spain t
Spain
Country
Type
Organisation’s Acronym
Organisation’s Full Name
1)
LATVIA TRANSP
Latvia
(CA) LU University of Latvia
(AE) CDPC The Centre of Disease Prevention and Control of Latvia
(AE) PSCUH Pauls Stradins Clinical University Hospital
(AE) RSU Riga Stradins university
2)
AUSTRIA TRANSP
Austria
(CA) GÖG Austrian National Public Health Institute
(AE) UWK Universität für Weiterbildung Krems
(AE) WGF (MA24) Wiener Gesundheitsfonds (as part of Magistratsabteilung 24)
(AE) CCIV Competence Center Integrierte Versorgung
(AE) UMIT TIROL UMIT TIROL – Private Universität für Gesundheitswissenschaften und -technologie GmbH
3)
Belgium t
Belgium
(CA) Sciensano Sciensano
(AE) BCR Belgian Cancer Register
(AE) CvKO Centrum voor KankerOpsporing vzw
4)
Croatia t
Croatia
(CA) CIPH / HZJZ Croatian Institute of Public Health (Hrvatski zavod za javno zdravstvo)
(AE) KBC Zagreb University Hospital Centre Zagreb (Klinički bolnički centar Zagreb)
deadline to nominate AE till August 17th
5)
Cyprus
Cyprus
(CA) MOH CY MINISTRY OF HEALTH CYPRUS
(AE) UCY UNIVERSITY OF CYPRUS
6)
Czechia
Czechia
(CA) ÚZIS Institute of Health Information and Statistics of the Czech Republic
7)
Denmark
Denmark
(CA) SST Danish Health Authority
(AE) RSYD Southern Region of Denmark
8)
Estonia
Estonia
(CA) NIHD National Institute for Health Development
(AE) UT University of Tartu
9)
Finalnd t
Finalnd
(CA) THL Finnish Institute of Health and Welfare
(AE) Cancer Society of Finland (incl. Finnish Cancer Registry)
10)
france t
France
(CA) INCa Institut National du Cancer
(AE) Unicancer
(AE) AP-HP Assistance Publique – Hôpitaux de Paris
(AE) HDH Health Data Hub
(AE) FHF Fédération Hospitalière de France (FHF) Cancer
(AE) SPLF Société de Pneumologie de Langue Française
(AE) Hospices Civiles de Lyon
(AE) SFR Société française de Radiologie
(AE) AFU Urofrance – Association française d’urologie
(AE) CHU De Toulouse
(AE) REFLIS Réseau francophone de littératie en santé
11)
Germany
Germany
(CA) RKI Robert Koch Institute – RKI, German Centre for Cancer Registry Data
(AE) DKG German Cancer Society Deutsche Krebsgesellschaft (DKG)
12)
Greece t
Greece
(CA) MoH Hellenic Ministry of Health – General Directorate of Public Health and Quality of Life – Directorate of Public and Environmental Health – Unit of Non-transmissible Diseases and Nutrition
(AE) 6th YPE DIOIKISI 6IS YGEIONOMIKIS PERIFEREIAS PELOPONNISOU KAI IONION NISON IPEIROU KAI DYTIKHS ELLADAS
(AE) 7HRC 7th Healthcare Region of Crete
13)
Hungary t
Hungary
(CA) Koranyi Koranyi National Institute for Pulmonology
(AE) NPHC (in Hungarian: NNK) National Center for Public Health and Pharmacy
14)
Iceland
Iceland
(CA) Primary Health Care of the Capital Area Primary Health Care of the Capital Area in Iceland
(AE) Directorate of Health Directorate of Health
15)
IRELAND TRANS
Ireland
(CA) DoH The Department of Health
(AE) HSE Health Service Executive
16)
Italy t
Italy
(CA) ISPRO ISTITUTO PER LO STUDIO, LA PREVENZIONE E LA RETE ONCOLOGICA
(AE) ISS Istituto Superiore di Sanità
(AE) MINSAL MINISTERO DELLA SALUTE
(AE) ASL TA ASL Taranto
(AE) ITGPII IRCCS Istituto Tumori “Giovanni Paolo II”
(AE) AUSLRE AUSL-IRCCS di Reggio Emilia
(AE) MaR Regione Marche
(AE) CPO AOU Città della Salute e della Scienza di Torino
(AE) PROMIS PROMIS
(AE) IRFMN Istituto di Ricerche Farmacologiche Mario Negri IRCCS
(AE) UNICATT Università Cattolica del Sacro Cuore
(AE) INT Fondazione Istituto nazionale dei Tumori IRCCS
(AE) LoR Regione Lombardia
(AE) Provincia autonoma PROVINCIA AUTONOMA DI BOLZANO – ALTO ADIGE
17)
Lithuania t
Lithuania
(CA) SAM LT MINISTRY OF HEALTH OF THE REPUBLIC OF LITHUANIA
(AE) SANTAROS LT VILNIUS UNIVERSITY HOSPITAL SANTAROS KLINIKOS
(AE) LSMUKK LT Hospital of Lithuanian University of Health Sciences Kauno Klinikos
18)
Moldova
Moldova
(CA) PMSI IO PMSI Institute of Oncology
19)
Malta t
Malta
(CA) MFH MINISTRY FOR HEAALTH
20)
holland transp
Netherlands
(CA) RIVM National Institute for Public Health and the Environment
(AE) MoH Ministry of health, welfare and sport
(AE) EMC Erasmus MC
(AE) RUMC Radboud UMC
21)
Norway
Norway
(CA) Hdir The Norwegian Directorate of Health
(AE) OUS Oslo University Hospital
22)
Poland t
Poland
(CA) MSCI Maria Sklodowska-Curie National Research Institute of Oncology
23)
Portugal t
Portugal
(CA) DGS Direção-Geral da Saúde/ Directorate-General of Health
24)
romania transp
Romania
(CA) NIPH National Institute of Public Health
(AE) NCMHFAD National Center for Mental Health and the Fight Against Drugs
(AE) Iasi RIO Iasi Regional Institute of Oncology
(AE) FCI Fundeni Clinical Institute
(AE) IOCN The Oncology Institute “Prof. Dr. Ion Chiricuta” Cluj-Napoca
25)
Slovakia
Slovakia
(CA) MoH SK Ministry of Health of the Slovak Republic
(AE) NOI National Oncology Institute
26)
Slovenia t
Slovenia
(CA) OI LJ Institute of Oncology Ljubljana
(AE) NIJZ NATIONAL INSTITUTE OF PUBLIC HEALTH
27)
Spain t
Spain
(CA) ICO Institut Català d’Oncologia
(AE) BIOSISTEMAK Instituto de Investigación en Sistemas de Salud
(AE) FISABIO Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
(AE) IACS Instituto Aragonés de Ciencias de la Salud
(AE) IDIVAL Fundación Instituto de Investigación Marqués de Valdecilla
(AE) IMIM Fundació Institut Hospital del Mar d’Investigacions Mèdiques
28)
Sweden
Sweden
(CA) SoS National Board of Health and Welfare
(AE) RCC Confederation of Regional Cancer Centres
29)
Ukraine
Ukraine
(CA) PHC “State institution “Public Health Center of the Ministry of Health of Ukraine”
(AE) IU NAMSU Academician O.F. Vozianov Institute of Urology of the National Academy of Medical Sciences of Ukraine
(AE) NCI NATIONAL CANCER INSTITUTE

eucanscreen logo move trasp

The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.

FaceBook
Twitter

Instagram

YouTube

LinkedIn

HaDEA EC

This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959

Print Friendly, PDF & Email
Μετάβαση στο περιεχόμενο